Information for the public

Eribulin (Halaven) is not normally available on the NHS for treating locally advanced or metastatic (secondary) breast cancer in adults who have had only 1 chemotherapy treatment.

If you have had only 1 chemotherapy treatment, your doctor should talk with you about other treatment options. If you are already taking eribulin, you should be able to continue until you and your doctor decide when best to stop.

Information and support

NHS Choices may be a good place to find out more about breast cancer in women and men.

These organisations can give you advice and support:

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-2915-3


This page was last updated: 28 March 2018